Oxybutynin
- Generic Name
- Oxybutynin
- Brand Names
- Ditropan, Gelnique, Kentera, Oxytrol, Kentera (previously Oxybutynin Nicobrand)
- Drug Type
- Small Molecule
- Chemical Formula
- C22H31NO3
- CAS Number
- 5633-20-5
- Unique Ingredient Identifier
- K9P6MC7092
- Background
Overactive bladder (OAB) is a common condition negatively impacting the lives of millions of patients worldwide. Due to its urinary symptoms that include nocturia, urgency, and frequency, this condition causes social embarrassment and a poor quality of life.
...
- Indication
Oxybutynin is indicated for the symptomatic treatment of overactive bladder, which causes urge urinary incontinence and frequency, and urgency. Oxybutynin may also be used for children aged 6 and above for the symptomatic management of detrusor muscle overactivity which has been found to be related to a neurological condition. Spina bifida is an example of a...
- Associated Conditions
- Bladder Spasms, Detrusor Hyperreflexia, Overactive Bladder Syndrome (OABS)
- Associated Therapies
- -
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.